HIV Associated Lipodystrophy Syndrome Treatment Market - Global Outlook and Forecast 2024-2031

Report ID: 1377068 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 HIV Associated Lipodystrophy Syndrome Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global HIV Associated Lipodystrophy Syndrome Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global HIV Associated Lipodystrophy Syndrome Treatment Overall Market Size
    2.1 Global HIV Associated Lipodystrophy Syndrome Treatment Market Size: 2021 VS 2028
    2.2 Global HIV Associated Lipodystrophy Syndrome Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top HIV Associated Lipodystrophy Syndrome Treatment Players in Global Market
    3.2 Top Global HIV Associated Lipodystrophy Syndrome Treatment Companies Ranked by Revenue
    3.3 Global HIV Associated Lipodystrophy Syndrome Treatment Revenue by Companies
    3.4 Top 3 and Top 5 HIV Associated Lipodystrophy Syndrome Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies HIV Associated Lipodystrophy Syndrome Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 HIV Associated Lipodystrophy Syndrome Treatment Players in Global Market
        3.6.1 List of Global Tier 1 HIV Associated Lipodystrophy Syndrome Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 HIV Associated Lipodystrophy Syndrome Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global HIV Associated Lipodystrophy Syndrome Treatment Market Size Markets, 2021 & 2028
        4.1.2 Specific Drug Treatment
        4.1.3 Cosmetic Corrective Treatment
    4.2 By Type - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue & Forecasts
        4.2.1 By Type - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue, 2017-2022
        4.2.2 By Type - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue, 2023-2028
        4.2.3 By Type - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Specialist Clinic
        5.1.4 Others
    5.2 By Application - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue & Forecasts
        5.2.1 By Application - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue, 2017-2022
        5.2.2 By Application - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue, 2023-2028
        5.2.3 By Application - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2021 & 2028
    6.2 By Region - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue & Forecasts
        6.2.1 By Region - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue, 2017-2022
        6.2.2 By Region - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue, 2023-2028
        6.2.3 By Region - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America HIV Associated Lipodystrophy Syndrome Treatment Revenue, 2017-2028
        6.3.2 US HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.3.3 Canada HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.3.4 Mexico HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe HIV Associated Lipodystrophy Syndrome Treatment Revenue, 2017-2028
        6.4.2 Germany HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.4.3 France HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.4.4 U.K. HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.4.5 Italy HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.4.6 Russia HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.4.8 Benelux HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia HIV Associated Lipodystrophy Syndrome Treatment Revenue, 2017-2028
        6.5.2 China HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.5.3 Japan HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.5.4 South Korea HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.5.6 India HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America HIV Associated Lipodystrophy Syndrome Treatment Revenue, 2017-2028
        6.6.2 Brazil HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.6.3 Argentina HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa HIV Associated Lipodystrophy Syndrome Treatment Revenue, 2017-2028
        6.7.2 Turkey HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.7.3 Israel HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
        6.7.5 UAE HIV Associated Lipodystrophy Syndrome Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Gilead Sciences
        7.1.1 Gilead Sciences Corporate Summary
        7.1.2 Gilead Sciences Business Overview
        7.1.3 Gilead Sciences HIV Associated Lipodystrophy Syndrome Treatment Major Product Offerings
        7.1.4 Gilead Sciences HIV Associated Lipodystrophy Syndrome Treatment Revenue in Global Market (2017-2022)
        7.1.5 Gilead Sciences Key News
    7.2 Amgen
        7.2.1 Amgen Corporate Summary
        7.2.2 Amgen Business Overview
        7.2.3 Amgen HIV Associated Lipodystrophy Syndrome Treatment Major Product Offerings
        7.2.4 Amgen HIV Associated Lipodystrophy Syndrome Treatment Revenue in Global Market (2017-2022)
        7.2.5 Amgen Key News
    7.3 Abbott
        7.3.1 Abbott Corporate Summary
        7.3.2 Abbott Business Overview
        7.3.3 Abbott HIV Associated Lipodystrophy Syndrome Treatment Major Product Offerings
        7.3.4 Abbott HIV Associated Lipodystrophy Syndrome Treatment Revenue in Global Market (2017-2022)
        7.3.5 Abbott Key News
    7.4 AstraZeneca
        7.4.1 AstraZeneca Corporate Summary
        7.4.2 AstraZeneca Business Overview
        7.4.3 AstraZeneca HIV Associated Lipodystrophy Syndrome Treatment Major Product Offerings
        7.4.4 AstraZeneca HIV Associated Lipodystrophy Syndrome Treatment Revenue in Global Market (2017-2022)
        7.4.5 AstraZeneca Key News
    7.5 AbbVie
        7.5.1 AbbVie Corporate Summary
        7.5.2 AbbVie Business Overview
        7.5.3 AbbVie HIV Associated Lipodystrophy Syndrome Treatment Major Product Offerings
        7.5.4 AbbVie HIV Associated Lipodystrophy Syndrome Treatment Revenue in Global Market (2017-2022)
        7.5.5 AbbVie Key News
    7.6 GlaxoSmithKline
        7.6.1 GlaxoSmithKline Corporate Summary
        7.6.2 GlaxoSmithKline Business Overview
        7.6.3 GlaxoSmithKline HIV Associated Lipodystrophy Syndrome Treatment Major Product Offerings
        7.6.4 GlaxoSmithKline HIV Associated Lipodystrophy Syndrome Treatment Revenue in Global Market (2017-2022)
        7.6.5 GlaxoSmithKline Key News
    7.7 Alfa Wassermann SPA
        7.7.1 Alfa Wassermann SPA Corporate Summary
        7.7.2 Alfa Wassermann SPA Business Overview
        7.7.3 Alfa Wassermann SPA HIV Associated Lipodystrophy Syndrome Treatment Major Product Offerings
        7.7.4 Alfa Wassermann SPA HIV Associated Lipodystrophy Syndrome Treatment Revenue in Global Market (2017-2022)
        7.7.5 Alfa Wassermann SPA Key News
    7.8 Theratechnologies
        7.8.1 Theratechnologies Corporate Summary
        7.8.2 Theratechnologies Business Overview
        7.8.3 Theratechnologies HIV Associated Lipodystrophy Syndrome Treatment Major Product Offerings
        7.8.4 Theratechnologies HIV Associated Lipodystrophy Syndrome Treatment Revenue in Global Market (2017-2022)
        7.8.5 Theratechnologies Key News
    7.9 Bristol-Myers Squibb
        7.9.1 Bristol-Myers Squibb Corporate Summary
        7.9.2 Bristol-Myers Squibb Business Overview
        7.9.3 Bristol-Myers Squibb HIV Associated Lipodystrophy Syndrome Treatment Major Product Offerings
        7.9.4 Bristol-Myers Squibb HIV Associated Lipodystrophy Syndrome Treatment Revenue in Global Market (2017-2022)
        7.9.5 Bristol-Myers Squibb Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. HIV Associated Lipodystrophy Syndrome Treatment Market Opportunities & Trends in Global Market
    Table 2. HIV Associated Lipodystrophy Syndrome Treatment Market Drivers in Global Market
    Table 3. HIV Associated Lipodystrophy Syndrome Treatment Market Restraints in Global Market
    Table 4. Key Players of HIV Associated Lipodystrophy Syndrome Treatment in Global Market
    Table 5. Top HIV Associated Lipodystrophy Syndrome Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global HIV Associated Lipodystrophy Syndrome Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global HIV Associated Lipodystrophy Syndrome Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies HIV Associated Lipodystrophy Syndrome Treatment Product Type
    Table 9. List of Global Tier 1 HIV Associated Lipodystrophy Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 HIV Associated Lipodystrophy Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - HIV Associated Lipodystrophy Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - HIV Associated Lipodystrophy Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - HIV Associated Lipodystrophy Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - HIV Associated Lipodystrophy Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Gilead Sciences Corporate Summary
    Table 31. Gilead Sciences HIV Associated Lipodystrophy Syndrome Treatment Product Offerings
    Table 32. Gilead Sciences HIV Associated Lipodystrophy Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Amgen Corporate Summary
    Table 34. Amgen HIV Associated Lipodystrophy Syndrome Treatment Product Offerings
    Table 35. Amgen HIV Associated Lipodystrophy Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. Abbott Corporate Summary
    Table 37. Abbott HIV Associated Lipodystrophy Syndrome Treatment Product Offerings
    Table 38. Abbott HIV Associated Lipodystrophy Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. AstraZeneca Corporate Summary
    Table 40. AstraZeneca HIV Associated Lipodystrophy Syndrome Treatment Product Offerings
    Table 41. AstraZeneca HIV Associated Lipodystrophy Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. AbbVie Corporate Summary
    Table 43. AbbVie HIV Associated Lipodystrophy Syndrome Treatment Product Offerings
    Table 44. AbbVie HIV Associated Lipodystrophy Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. GlaxoSmithKline Corporate Summary
    Table 46. GlaxoSmithKline HIV Associated Lipodystrophy Syndrome Treatment Product Offerings
    Table 47. GlaxoSmithKline HIV Associated Lipodystrophy Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. Alfa Wassermann SPA Corporate Summary
    Table 49. Alfa Wassermann SPA HIV Associated Lipodystrophy Syndrome Treatment Product Offerings
    Table 50. Alfa Wassermann SPA HIV Associated Lipodystrophy Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. Theratechnologies Corporate Summary
    Table 52. Theratechnologies HIV Associated Lipodystrophy Syndrome Treatment Product Offerings
    Table 53. Theratechnologies HIV Associated Lipodystrophy Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 54. Bristol-Myers Squibb Corporate Summary
    Table 55. Bristol-Myers Squibb HIV Associated Lipodystrophy Syndrome Treatment Product Offerings
    Table 56. Bristol-Myers Squibb HIV Associated Lipodystrophy Syndrome Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. HIV Associated Lipodystrophy Syndrome Treatment Segment by Type in 2021
    Figure 2. HIV Associated Lipodystrophy Syndrome Treatment Segment by Application in 2021
    Figure 3. Global HIV Associated Lipodystrophy Syndrome Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global HIV Associated Lipodystrophy Syndrome Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global HIV Associated Lipodystrophy Syndrome Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by HIV Associated Lipodystrophy Syndrome Treatment Revenue in 2021
    Figure 8. By Type - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global HIV Associated Lipodystrophy Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America HIV Associated Lipodystrophy Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 12. US HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe HIV Associated Lipodystrophy Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia HIV Associated Lipodystrophy Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 24. China HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America HIV Associated Lipodystrophy Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa HIV Associated Lipodystrophy Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE HIV Associated Lipodystrophy Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Gilead Sciences HIV Associated Lipodystrophy Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Amgen HIV Associated Lipodystrophy Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Abbott HIV Associated Lipodystrophy Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. AstraZeneca HIV Associated Lipodystrophy Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. AbbVie HIV Associated Lipodystrophy Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. GlaxoSmithKline HIV Associated Lipodystrophy Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Alfa Wassermann SPA HIV Associated Lipodystrophy Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Theratechnologies HIV Associated Lipodystrophy Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Bristol-Myers Squibb HIV Associated Lipodystrophy Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
66
Frequently Asked Questions
HIV Associated Lipodystrophy Syndrome Treatment Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
HIV Associated Lipodystrophy Syndrome Treatment Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
HIV Associated Lipodystrophy Syndrome Treatment Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Slimming Aids Market

Slimming aids are defined as dietary supplements that help an individual lose or maintain the des ... Read More